CHOKSI LABORATORIES LTD.
NSE : NABSE : 526546ISIN
CODE : INE493D01013Industry : Hospital & Healthcare ServicesHouse
: Private
BSE61.500 (0 % )
PREV CLOSE (Rs.) 61.50
OPEN PRICE (Rs.) 63.65
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 647
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE
This Company is not listed in NSE
Board Meetings
| Source Date | Board Meeting Date | Details |
|---|---|---|
| 22-Mar-2024 | 27-Mar-2024 | Inter alia, to consider and approve:- 1. To Consider and approve the appointment of Mrs. Abha Shastri (DIN: 00065772) as Additional Independent Director of the company w.e.f. 01st April, 2024 2. To take on record the cessation of directorship of Mr. Sudarshan Shastri (DIN: 00155105) as Independent Director of the company w.e.f. 01st April, 2024 due to completion of his term; 3. To consider, reviews and finalize the matters to be included in the Postal Ballot Notice, E-voting period and other matters pursuant to which. 4. Any other item may be taken up for consideration with the permission of the Chairman and presence of at least one independent Director. If any |
| 29-Jan-2024 | 03-Feb-2024 | Quarterly Results |
| 03-Nov-2023 | 10-Nov-2023 | Quarterly Results |
| 04-Aug-2023 | 12-Aug-2023 | A.G.M. & Quarterly Results |
| 03-Jul-2023 | 05-Jul-2023 | Inter alia, to consider and approve :- 1. To Consider and approve the Appointment of Mr. Prakhar Dubey as Company Secretary and Compliance Officer of the Company. 2. To consider and approve the Resignation of Mr. Yash Gupta from the post of Company Secretary and Compliance Officer of the Company.; 3. To appoint Mrs. Meenaxi Patidar as an Additional Director of the Company in the category of the Independent Director of the Company subject to the Conformation of the Members; |
| 23-May-2023 | 29-May-2023 | Audited Results & Quarterly Results |
| 03-Feb-2023 | 13-Feb-2023 | Quarterly Results |
| 09-Jan-2023 | 12-Jan-2023 | Inter alia, to consider and approve the transfer of all Loan Facilities from State Bank of India to HDFC Bank Ltd |
| 07-Dec-2022 | 12-Dec-2022 | Inter alia, to consider and approve the sale of the Land and Building of the Company situated at 4/3, Manormaja Ganj, Indore-452001 being a related party transaction; |
| 04-Nov-2022 | 12-Nov-2022 | Quarterly Results |
